<DOC>
	<DOCNO>NCT00973141</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness different dose JNJ-42160443 placebo treatment chronic , moderate severe knee hip pain patient diagnosis osteoarthritis .</brief_summary>
	<brief_title>A Dose-ranging Study Safety Effectiveness JNJ-42160443 add-on Treatment Patients With Osteoarthritis-related Pain</brief_title>
	<detailed_description>This current study randomize ( study drug assign chance ) , double-blind ( neither physician patient know name assign drug ) study evaluate safety effectiveness different dose JNJ-42160443 compare placebo treatment patient diagnosis osteoarthritis hip knee moderate severe pain control standard pain medications.Osteoarthritis chronic disease affect joint , characterize degeneration cartilage bone . The duration study approximately 133 week ( 3-week screening phase , 12-week double-blind efficacy phase , 92-week double-blind extension phase , 26-week post treatment phase ) .JNJ-42160443 ( 10 mg/mL ) match placebo give subcutaneous ( injection skin ) ( SC ) every 4 week administer study 1 5 JNJ-42160443 dosages:1 mg every 4 week , 3 mg every 4 week , 3 mg every 8 week , 6 mg every 8 week ; 10 mg every 8 week , match placebo approximately 104 week ( 12-week double-blind efficacy phase + 92-week double-blind extension phase ) .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<criteria>Diagnosis osteoarthritis hip knee ; Have average daily pain intensity score &gt; =5 average last 3 day treatment assignment ; Receiving stable dose nonsteroidal antiinflammatory drug minimum 5 day week 4 week screen stable dose immediaterelease opioids minimum 5 day week 4 week screening , exceed 200 mg oral morphine equivalent per day stable dose long acting opioids 4 week screen ; exceed 200 mg oral morphine equivalent per day ; Have mini mental state examination score &gt; =26 screen . History within past year following : seizure disorder ; intrathecal therapy ventricular shunt , mild moderate traumatic brain injury , stroke , transient ischemic attack , meningitis ; History brain injury within past 15 year consist &gt; = 1 follow , residual sequalae suggest transient change consciousness : brain contusion , intracranial hematoma , either unconsciousness posttraumatic amnesia last 24 hour ; History epilepsy multiple sclerosis ; Current diagnosis fibromyalgia , complex regional pain syndrome ( include reflex sympathetic dystrophy causalgia ) , study joint pain cause secondary infection , pain cause confirm suspected neoplasm ; Any new unresolved neurologic deficit , include progressive deficit , within 6 month screen</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Moderate severe , osteoarthritis-related pain</keyword>
	<keyword>Osteoarthritis-related pain</keyword>
	<keyword>Moderate severe chronic pain</keyword>
	<keyword>JNJ-42160443</keyword>
</DOC>